DeepMed Research

THE MILTON S. HERSHEY MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

JVRS-100 for the Treatment of Patients With Relapsed or Refractory Leukemia

Phase 1

Completed

Conditions: Leukemia

Interventions: Drug: JVRS-100

First Posted Date: 2009-03-12

Last Posted Date: 2019-04-05

Lead Sponsor: Milton S. Hershey Medical Center

Target Recruit Count: 11

Registration Number: NCT00860522

Locations: 🇺🇸
Penn State Hershey Cancer Institute, Hershey, Pennsylvania, United States

Spinal Anesthesia Induced Hypotension During Cesarean Section

Phase 4

Completed

Conditions: Hypotension

Interventions: Other: Colloid administration
Other: Crystalloid administration
Drug: phenylephrine infusion

First Posted Date: 2009-02-19

Last Posted Date: 2017-10-16

Lead Sponsor: Milton S. Hershey Medical Center

Target Recruit Count: 82

Registration Number: NCT00846651

Locations: 🇺🇸
PennState Hershey Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States

Oncaspar/Doxil/Decadron in Patients With Refractory Lymphoid Malignancies

Phase 2

Terminated

Conditions: Non-hodgkins Lymphoma
Hodgkins Lymphoma
Multiple Myeloma

Interventions: Drug: Oncaspar, Doxil, Decadron

First Posted Date: 2009-02-05

Last Posted Date: 2017-07-24

Lead Sponsor: Milton S. Hershey Medical Center

Target Recruit Count: 13

Registration Number: NCT00837200

Locations: 🇺🇸
Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States

Comparison of ProSeal Laryngeal Mask Airway to Laryngeal Mask Airway Supreme

Phase 4

Completed

Conditions: Adverse Effect of Unspecified General Anesthetics

Interventions: Device: Supreme Laryngeal mask airway
Device: Proseal laryngeal mask airway

First Posted Date: 2009-02-04

Last Posted Date: 2016-04-15

Lead Sponsor: Milton S. Hershey Medical Center

Target Recruit Count: 52

Registration Number: NCT00836095

Locations: 🇺🇸
PennState Hershey Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States

Trial of RAD001 in Triple Negative Metastatic Breast Cancer

Phase 2

Terminated

Conditions: Breast Cancer

Interventions: Drug: RAD 001

First Posted Date: 2009-01-22

Last Posted Date: 2014-01-13

Lead Sponsor: Milton S. Hershey Medical Center

Target Recruit Count: 6

Registration Number: NCT00827567

Locations: 🇺🇸
Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States

Trial of Sunitinib for Refractory Malignant Ascites

Phase 2

Terminated

Conditions: Ascites

Interventions: Drug: Sunitinib

First Posted Date: 2008-11-24

Last Posted Date: 2017-12-20

Lead Sponsor: Milton S. Hershey Medical Center

Target Recruit Count: 4

Registration Number: NCT00796861

Locations: 🇺🇸
Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States

Opioid Growth Factor (OGF) and Gemcitabine: Novel Treatment for Pancreatic Cancer

Phase 1

Terminated

Conditions: Pancreatic Cancer

Interventions: Drug: Gemcitabine
Biological: Opioid Growth Factor (OGF)

First Posted Date: 2008-10-31

Last Posted Date: 2018-09-06

Lead Sponsor: Milton S. Hershey Medical Center

Target Recruit Count: 4

Registration Number: NCT00783172

Locations: 🇺🇸
Lehigh Valley Hospital and Health Network, Allentown, Pennsylvania, United States
🇺🇸
Penn State Hershey Medical Center, Hershey, Pennsylvania, United States

Long Term Prognosis of MRI Diagnosed Partial Thickness Tears of the Rotator Cuff

Completed

Conditions: Rotator Cuff Tear

First Posted Date: 2008-10-24

Last Posted Date: 2015-02-27

Lead Sponsor: Milton S. Hershey Medical Center

Target Recruit Count: 10

Registration Number: NCT00779415

Locations: 🇺🇸
Penn State College of Medicine, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States

Electromyography Evaluation of Subscapularis Function After Total Shoulder Arthroplasty

Completed

Conditions: Osteoarthritis

Interventions: Other: Evaluation

First Posted Date: 2008-10-24

Last Posted Date: 2023-11-03

Lead Sponsor: Milton S. Hershey Medical Center

Target Recruit Count: 32

Registration Number: NCT00779974

Locations: 🇺🇸
Penn State College of Medicine, Penn State Milton S. Herhsey Medical Center, Hershey, Pennsylvania, United States

Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections

Phase 1

Conditions: Cancer

First Posted Date: 2008-10-09

Last Posted Date: 2013-12-18

Lead Sponsor: Milton S. Hershey Medical Center

Target Recruit Count: 20

Registration Number: NCT00769613

Locations: 🇺🇸
Penn State Cancer Institute at Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy